Skip to content

Drug interactions

Irbesartan + Siponimod

Severity: Minor

Irbesartan and Siponimod: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Irbesartan is a CYP2C9 substrate with weak inhibitory activity at most, so any rise in siponimod exposure is likely small. The labeled concern applies to moderate CYP2C9 inhibitors combined with CYP3A4 inhibitors.

What this interaction means in plain words

Irbesartan and Siponimod have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Irbesartan belongs to Cardiovascular; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible weak competition for CYP2C9, a main siponimod metabolic pathway.

What to do

No routine change is needed. Monitor heart rate and for siponimod adverse effects if other CYP2C9 or CYP3A4 inhibitors are also used.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irbesartan and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irbesartan with Siponimod?

MediHelp rates the interaction as minor. Irbesartan and Siponimod have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Irbesartan is a CYP2C9 substrate with weak inhibitory activity at most, so any rise in siponimod exposure is likely small. The labeled concern applies to moderate CYP2C9 inhibitors combined with CYP3A4 inhibitors.

How serious is the interaction between Irbesartan and Siponimod?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Monitor heart rate and for siponimod adverse effects if other CYP2C9 or CYP3A4 inhibitors are also used.

What other medicines interact with Irbesartan?

MediHelp also lists interactions of Irbesartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Irbesartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in